EP. 2: Dr. Wainberg on Optimal Frontline Treatment Strategies for Metastatic ESCCJanuary 17th 2023
Zev A. Wainberg, MD, discusses standard frontline treatment approaches for patients with metastatic esophageal squamous cell carcinoma and highlights data supporting the use of tislelizumab in combination with chemotherapy in ESCC.
EP. 3: Dr. Pishvaian on the Implications of the RATIONALE-306 Trial in ESCCJanuary 25th 2023
Michael Jon Pishvaian, MD, PhD, discusses the clinical implications of the phase 3 RATIONALE 306 trial and the adverse effects associated with immunotherapy in patients with advanced esophageal squamous cell carcinoma.
EP. 6: Dr. Mehta on Frontline and Adjuvant Treatments in ESCCFebruary 10th 2023
Rutika Mehta, MD, MPH, discusses which patients with esophageal squamous cell carcinoma may benefit most from the different frontline treatment options available and highlights key treatment developments with adjuvant immunotherapy plus chemotherapy.
EP. 7: Dr. Kelly on Trials Evaluating Frontline Immunotherapy Combinations in ESCCFebruary 23rd 2023
Ronan J. Kelly, MD, MBA, discusses the variety of clinical trials investigating immunotherapy with or without chemotherapy in patients with esophageal squamous cell carcinoma.